Orbis Health Solutions
Orbis Health Solutions, founded in 2009, focuses on developing immunotherapies and transformative medicines to treat cancer and immune-mediated conditions, utilizing its proprietary Yeast Cell Wall Particle technology.
Company Overview
Orbis Health Solutions, founded in 2009, is dedicated to eradicating cancer and immune-mediated conditions through advanced immunotherapies. The company focuses on developing transformative medicines that target the body's immune system to foster recovery and restore health. Located in Greenville, South Carolina, Orbis Health Solutions is part of a burgeoning biosciences industry hub.
Innovative Immunotherapy Products
Orbis Health Solutions is at the forefront of immunotherapy, creating groundbreaking medicines designed to leverage and enhance the body’s immune response. One of its signature technologies includes the Yeast Cell Wall Particle (YCWP) vaccine delivery platform, aimed at optimizing the effectiveness of vaccines.
Cancer Vaccine Development
Orbis Health Solutions is actively developing a cancer vaccine specifically for companion animals, focusing on osteosarcoma in dogs. This initiative seeks to bring innovative cancer treatment options to veterinary medicine, potentially improving outcomes for pets suffering from this aggressive disease.
COVID-19 DNA Vaccine Research
To address the global COVID-19 pandemic, Orbis Health Solutions is pursuing the development of a DNA vaccine designed to minimize side effects often associated with mRNA vaccines. This approach aims to offer a safer alternative while maintaining strong efficacy in combating the virus.
Clinical Trials and Research
Orbis Health Solutions conducts extensive clinical trials to validate the efficacy of its treatments. This includes a Phase IIb trial for a personalized cancer vaccine, underscoring the company's commitment to advancing personalized medicine and delivering targeted, effective healthcare solutions.